FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/074389 [Registered on: 25/09/2024] Trial Registered Prospectively
Last Modified On: 17/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Mustadi kwatha will be given to Patients of Diabetes Mellitus. 
Scientific Title of Study   Comparative Clinical Evaluation of Mustadi kwatha and Ghavati in Madhumeha (Diabetes Mellitus Type-2) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vikrant Kumar 
Designation  Pg Scholar Kayachikitsa Department 
Affiliation  Uttarakhand Ayurved University, Gurukul Campus Haridwar 
Address  OPD No. 5 Department of Kayachikitsa, Uttarakhand Ayurved University, Gurukul Campus Haridwar 249404 India.
OPD No. 5 Department of Kayachikitsa, Uttarakhand Ayurved University, Gurukul Campus Haridwar 249404 India.
Hardwar
UTTARANCHAL
249404
India 
Phone  09568325329  
Fax    
Email  vikrantkumar11061997@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Punita Pandey 
Designation  Professor 
Affiliation  Uttarakhand Ayurved University, Gurukul Campus Haridwar 
Address  OPD No. 5 Department of Kayachikitsa, Uttarakhand Ayurved University, Gurukul Campus Haridwar 249404 India.
OPD No. 5 Department of Kayachikitsa, Uttarakhand Ayurved University, Gurukul Campus Haridwar 249404 India.
Hardwar
UTTARANCHAL
249404
India 
Phone  9319394485  
Fax    
Email  pandey.punita62@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vikrant Kumar 
Designation  Pg Scholar Kayachikitsa Department 
Affiliation  Uttarakhand Ayurved University, Gurukul Campus Haridwar 
Address  OPD No. 5 Department of Kayachikitsa, Uttarakhand Ayurved University, Gurukul Campus Haridwar 249404 India.
OPD No. 5 Department of Kayachikitsa, Uttarakhand Ayurved University, Gurukul Campus Haridwar 249404 India.
Hardwar
UTTARANCHAL
249404
India 
Phone  09568325329  
Fax    
Email  vikrantkumar11061997@gmail.com  
 
Source of Monetary or Material Support  
Vikrant Kumar Pg Department of Kayachikitsa, Uttarakhand Ayurved University, Gurukul Campus Haridwar 249404 India 
 
Primary Sponsor  
Name  Vikrant Kumar 
Address  Pg Department of Kayachikitsa, Uttarakhand Ayurved University, Gurukul Campus Haridwar 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vikrant Kumar  Uttarakhand Ayurved University, Gurukul Campus Haridwar  OPD No. 5 Department of Kayachikitsa Uttarakhand Ayurved University, Gurukul Campus Haridwar
Hardwar
UTTARANCHAL 
09568325329

vikrantkumar11061997@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Uttarakhand Ayurved University, Gurukul Campus, Hardwar.  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E118||Type 2 diabetes mellitus with unspecified complications. Ayurveda Condition: PRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: mustadi kwatha, Reference: charak sutra sthana chapter 23 and shloka number 12 and 13, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: -
(2) Medicine Name: mustadi kwatha ghanavati, Reference: charak sutra sthana chapter 23 and shloka number 12 and 13, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Fasting blood glucose level (FBS) more than or equal 126mg/dl to less than or equal 350mg/dl.
2. Post prandial blood sugar level (PPBS) more than or equal to 200mg/dl to less than or equal to 410mg/dl.
3. HbA1c more than or equal to 6.5 percentage to less than and equal to 13 percentage.
4. Known case of diabetes mellitus type 2.  
 
ExclusionCriteria 
Details  1. Patients of type 1 Diabetes Mellitus.
2. Chronicity more than 10 year.
3. Blood sugar- fasting blood sugar level more 350mg/dl.
4. Post Prandial blood sugar level more 410mg/dl.
5. Patients having complications.
6. Patients suffering from any serious medical or surgical illness. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
relief in subjective parameters.
1. Prabhutmutrata (Polyuria)
2. Trishnadhikya (Polydipsia)
3. Kshudhadhikya (Polyphagia)
4. Atinidra/ Nidradhikya (Increased sleep)
5. Kara-pada-taladaha (Burning sensation of both palms and feet)
6. Kara-pada-talasuptata (Numbness of both palms and feet)
 
4-6 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
relief in objective parameters.
• Fasting blood glucose level (FBS) equal or more than 126mg/dl & equal or less than350mg/dl.
• Post prandial blood sugar level (PPBS) equal or more than200mg/dl & equal or less than 410mg/dl.
• HbA1c equal or more than 6.5% & equal and less than 13%  
assessment will be done on 0th day , 30 day , 60 day and 90th day, for FBS and PPBS. And Hba1c will be done on 0th day and 90 day. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is COMPARATIVE CLINICAL EVALUATION OF MUSTADI KWATHA & GHANVATI IN MADHUMEHA (DIABETES MELLITUS TYPE-2) for age group between 20-65 years,  for 90 days. The study will be conducted at UAU gurukul campus, Haridwar on 40 patients. in this study 20 patients will be administered mustadi kwatha and 20 patient will be administerd mustadi ghana vati for 90 days. The assessment will be done on the basis of subjective and objective parameters. The study will be conducted at OPD/IPD level of P.G department of kayachikitsa. The assessment will be done at the interval of 30 days of the clinical trial and the results obtained will be tabulated and statically analyzed using appropriate tests. 
Close